Related Experiment Video

Updated: Oct 5, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

[Bronchopulmonary aspergillosis: new developments]

P Germaud1, K Renaudin, I Danner

  • 1Service de Pneumologie, CHRU Nantes, Hôpital G. et R. Laënnec, 44093 Nantes Cedex.

Revue Des Maladies Respiratoires
|July 27, 2001
PubMed

Insights

Diagnosing and preventing bronchopulmonary aspergillosis in immunocompromised patients and those with COPD presents challenges. Advances in imaging and mycology, alongside improved antifungal treatments, offer better prognoses for these serious fungal infections.

Area of Science:

  • Pulmonology
  • Mycology
  • Infectious Diseases

Context:

  • Bronchopulmonary aspergillosis (BPA) is gaining attention, particularly invasive forms in immunocompromised individuals.
  • These fungal infections are common in patients with chronic obstructive pulmonary disease (COPD).
  • Differentiating between aspergilloma and chronic necrotizing pulmonary aspergillosis poses diagnostic difficulties.

Purpose:

  • To highlight diagnostic and prevention challenges in invasive pulmonary aspergillosis.
  • To discuss the difficulties in distinguishing between aspergilloma and chronic necrotizing pulmonary aspergillosis.
  • To review the current understanding and therapeutic approaches for allergic bronchopulmonary aspergillosis.

Summary:

  • Recent advancements in thoracic computed tomography (CT) scans and mycological diagnostic methods have improved the identification of various forms of aspergillosis.
  • Optimal use of antifungal agents, including amphotericin B, lipid formulations, and azoles, is crucial.
  • Surgical resection may be necessary in select cases.

Impact:

  • Improved diagnostic accuracy for pulmonary aspergillosis.
  • Enhanced therapeutic strategies for invasive and allergic forms of the disease.
  • Better patient outcomes and prognosis through integrated treatment approaches.

More Related Videos

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: